Position in BMY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,571,104
+$2,881,599 QoQ
Shares Held
223,761
+12.9% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Derivatives in BMY
reported options exposure · as of Dec 31, 2021CallValue
$37,410
CallShares
600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MAI Capital Management holds $463,973,037 across 18 Drug Manufacturers - General names. BMY ranks #6 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
548,990 | $134,195,115 | |
| 2 | ABBV |
AbbVie Inc.
|
577,833 | $125,672,899 | |
| 3 | LLY |
ELI LILLY & Co
|
96,089 | $88,379,779 | |
| 4 | MRK |
Merck & Co., Inc.
|
335,023 | $40,299,916 | |
| 5 | AMGN |
Amgen Inc
|
87,280 | $30,709,468 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
223,761 | $13,571,104 | |
| 7 | PFE |
Pfizer Inc
|
420,692 | $11,813,031 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
44,349 | $6,180,920 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,571,104 | 223,761 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,689,505 | 198,174 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,960,240 | 176,502 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $7,443,385 | 160,799 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $10,344,025 | 169,602 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,833,747 | 173,864 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,037,333 | 116,686 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $5,936,298 | 142,940 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $33,040,549 | 609,267 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $29,330,899 | 571,641 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $30,229,843 | 520,845 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $34,202,250 | 534,828 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $36,961,082 | 533,272 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $39,183,610 | 544,595 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $37,266,941 | 524,222 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $34,138,797 | 443,361 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $27,525,007 | 376,900 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $37,410 | 600 | Call | Sole | 2022-02-11 | |
| 2021-12-31 | $17,207,664 | 275,985 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $12,603,979 | 213,013 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $13,302,659 | 199,082 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $12,152,588 | 192,501 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $11,583,668 | 186,743 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $20,960,722 | 347,665 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $19,958,190 | 339,425 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $8,370,977 | 150,179 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||